The ROE as of December 2025 (TTM) for CASI Pharmaceuticals, Inc. (CASI) is 358.32%

According to CASI Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current ROE is 358.32%. This represents a change of -365.81% compared to the average of -134.80% of the last 4 quarters.

CASI Pharmaceuticals, Inc. (CASI) Historical ROE (quarterly & annually)

How has CASI ROE performed in the past?

The mean historical ROE of CASI Pharmaceuticals, Inc. over the last ten years is -246.93%. The current 358.32% ROE has changed -245.11% with respect to the historical average. Over the past ten years (40 quarters), CASI's ROE was at its highest in in the March 2025 quarter at 133.21%. The ROE was at its lowest in in the December 2024 quarter at -776.34%.

CASI Pharmaceuticals, Inc. (CASI) ROE by Quarter and Year

Discovering the peaks and valleys of CASI Pharmaceuticals, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

CASI Pharmaceuticals, Inc. (CASI) Average ROE

How has CASI ROE performed in the past?

The current ROE of CASI Pharmaceuticals, Inc. (CASI) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

CASI Pharmaceuticals, Inc. (CASI) ROE vs. Peers

How is CASI’s ROE compared to its peers?

CASI Pharmaceuticals, Inc.’s ROE is less than Clearside Biomedical, Inc. (65.87%), greater than Cingulate Inc. (-842.45%), greater than Entero Therapeutics, Inc. (-31.69%), less than Curis, Inc. (354.21%), greater than Pelthos Therapeutics Inc. (-210.32%), greater than NuCana plc (-580.99%), greater than Palisade Bio, Inc. (-240.71%), greater than Allarity Therapeutics, Inc. (-112.05%), greater than Kairos Pharma, Ltd. (-79.19%), greater than Lisata Therapeutics, Inc. (-78.18%),

Build a custom stock screener for CASI Pharmaceuticals, Inc. (CASI) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like CASI Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

CASI Pharmaceuticals, Inc. (CASI) and other stocks custom spreadsheet templates

The easiest way to analyze a company like CASI Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.